Insulin-Like Growth Factor Receptor I (IGF-IR) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Are Expressed on the Circulating Epithelial Tumor Cells of Breast Cancer Patients

Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy

(2015) Zoë Davison et al.   NEOPLASIA

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

(2011) Areti Strati et al.   BMC CANCER

Promising molecular targeted therapies in breast cancer

(2011) Radha Munagala et al.   INDIAN JOURNAL OF PHARMACOLOGY

Efficacy control of therapy using circulating epithelial tumor cells (CETC) as “Liquid Biopsy”: trastuzumab in HER2/neu-positive breast carcinoma

(2011) Katharina Pachmann et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cells

(2010) B. C. Browne et al.   ANNALS OF ONCOLOGY

Circulating and Disseminated Tumor Cells in the Management of Breast Cancer

(2009) Jeffrey S. Ross et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Circulating tumor cells in breast cancer

(2009) Michail Ignatiadis et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse

(2008) Katharina Pachmann et al.   JOURNAL OF CLINICAL ONCOLOGY

IGF and Insulin Receptor Signaling in Breast Cancer

(2008) Antonino Belfiore et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA